Insider Transactions in Q1 2026 at Selecta Biosciences Inc (SELB)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2026
|
Blaine Davis Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,591
-8.04%
|
$63,546
$6.82 P/Share
|
|
Jan 06
2026
|
Milos Miljkovic Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,573
-5.73%
|
$21,438
$6.82 P/Share
|
|
Jan 06
2026
|
Carsten Brunn President and CEO |
SELL
Open market or private sale
|
Direct |
23,766
-6.84%
|
$142,596
$6.82 P/Share
|
|
Jan 02
2026
|
Murat Kalayoglu Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+0.51%
|
-
|
|
Jan 02
2026
|
Timothy A Springer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+0.03%
|
-
|
|
Jan 02
2026
|
Michael Singer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+4.43%
|
-
|
|
Jan 02
2026
|
Emily English Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,000
+20.3%
|
-
|
|
Jan 02
2026
|
Timothy C Barabe Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+4.36%
|
-
|
|
Jan 02
2026
|
Blaine Davis Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,000
+21.92%
|
-
|
|
Jan 02
2026
|
June Ann Seymour Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+50.0%
|
-
|
|
Jan 02
2026
|
Patrick J Zenner Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+16.69%
|
-
|
|
Jan 02
2026
|
Milos Miljkovic Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
27,000
+30.2%
|
-
|
|
Jan 02
2026
|
Kemal Malik Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+18.93%
|
-
|
|
Jan 02
2026
|
Carsten Brunn President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
143,200
+29.19%
|
-
|
|
Jan 02
2026
|
Nishan M De Silva Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,600
+18.62%
|
-
|